Ignite Creation Date:
2024-05-06 @ 7:47 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02609958
Status:
COMPLETED
Last Update Posted:
2018-05-29
First Post:
2015-11-08
Brief Title:
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
Sponsor:
Organization:
ASLAN Pharmaceuticals